Suchergebnisse - "Dorward, Jienchi"

PubPharm (9)

1

Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2024

von Dorward, J. | Sookrajh, Y. | Lessells, R. | +9

2

Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy

enthalten in: AIDS (London, England) | 2024

von Dorward, J. | Govender, K. | Moodley, P. | +9

3

Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa : a retrospective cohort study

enthalten in: The Lancet. Global health | 2024

von Asare, K. | Sookrajh, Y. | van der Molen, J. | +8

4

Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa

enthalten in: Open forum infectious diseases | 2023

von Asare, K. | Lewis, L. | van der Molen, J. | +8

5

Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy

enthalten in: Journal of the International AIDS Society | 2023

von Dorward, J. | Lessells, R. | Govender, K. | +9

6

Point-of-Care Viral Load Testing to Manage HIV Viremia During the Rollout of Dolutegravir-Based ART in South Africa : A Randomized Feasibility Study (POwER)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2023

von Dorward, J. | Sookrajh, Y. | Lessells, R. | +13

7

Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa : a retrospective cohort study

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Asare, K. | Sookrajh, Y. | van der Molen, J. | +8

8

Dolutegravir in sub-Saharan Africa : context is crucial

enthalten in: The lancet. HIV | 2019

von Dorward, J. | Hamers, R.

CommentOn: Lancet HIV. 2019 Feb;6(2):e116-e127. - PMID 30503325

9

Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries : uncertainties and opportunities for implementation and research

enthalten in: The lancet. HIV | 2018

von Dorward, J. | Lessells, R. | Drain, P. | +5

1
[1]